Related Experiment Video
Updated: Jan 8, 2026
Biosensor for Detection of Antibiotic Resistant Staphylococcus Bacteria
Published on: May 8, 2013
Eradicating extra- and intra-cellular Staphylococcus aureus and MRSA with little accumulation of resistance by a
Xiulian Liu1, Xuwen Da2, Yao Wu1
1Key Laboratory of Photochemical Conversion and Optoelectronic Materials, Technical Institute of Physics and Chemistry, Chinese Academy of Sciences, Beijing, 100190, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Abstract:
Staphylococcus aureus (S. aureus), especially the drug resistant strains, has emerged as one of the leading causes of lethal bacterial infections. Novel antibacterial agents, which can eradicate resistant pathogens without readily inducing drug resistance during long-term usage, are highly desirable. In this work, TPAMe-BODIPY with a high DNA binding affinity was designed and synthesized to achieve such a goal. Thanks to the two "Y" shape structures with four positive charges, TPAMe-BODIPY can strongly bind to bacterial DNA and activate the Save Our Souls (SOS) response in pathogens, consequently leading to quick generation of a high level of reactive oxygen species (ROS). Antibacterial results indicated that TPAMe-BODIPY can eradicate extra- and intra-cellular S. aureus and methicillin-resistant S. aureus (MRSA), surpassing the performances of traditional antibiotics gentamicin and ampicillin both in vitro and in vivo. Most importantly, S. aureus cells did not exhibit obvious resistance against TPAMe-BODIPY during continual incubation at sub-lethal concentrations for 20 days, which could be ascribed to the appealing multi-targeted antibacterial mechanism exerted by ROS. These results can provide new sights for developing novel antibacterial agents to fight against more and more popular drug resistance.
Insights
A novel compound, TPAMe-BODIPY, effectively eliminates drug-resistant Staphylococcus aureus (S. aureus) and methicillin-resistant S. aureus (MRSA) infections. This agent activates bacterial SOS response and reactive oxygen species (ROS) generation, showing no induced resistance over 20 days.
Area of Science:
- Medicinal Chemistry
- Antimicrobial Agents
- Molecular Biology
Background:
- Drug-resistant Staphylococcus aureus (S. aureus), including methicillin-resistant S. aureus (MRSA), poses a significant threat due to lethal bacterial infections.
- Development of novel antibacterial agents that overcome existing resistance and avoid inducing further resistance is crucial.
Purpose of the Study:
- To design and synthesize a novel compound, TPAMe-BODIPY, with high DNA binding affinity for effective antibacterial activity.
- To evaluate the efficacy of TPAMe-BODIPY against S. aureus and MRSA, both in vitro and in vivo.
- To investigate the potential for resistance development against TPAMe-BODIPY.
Main Methods:
- Synthesis of TPAMe-BODIPY, characterized by its "Y" shape structure and four positive charges for DNA binding.
- Assessment of TPAMe-BODIPY's ability to bind bacterial DNA and activate the Save Our Souls (SOS) response.
- Evaluation of reactive oxygen species (ROS) generation induced by TPAMe-BODIPY.
- In vitro and in vivo antibacterial assays comparing TPAMe-BODIPY with gentamicin and ampicillin.
- Long-term resistance studies involving continuous incubation of S. aureus with sub-lethal concentrations of TPAMe-BODIPY.
Main Results:
- TPAMe-BODIPY demonstrated strong binding to bacterial DNA, activating the SOS response and leading to significant ROS generation.
- The compound effectively eradicated both extracellular and intracellular S. aureus and MRSA in vitro and in vivo.
- TPAMe-BODIPY outperformed traditional antibiotics gentamicin and ampicillin in antibacterial efficacy.
- Crucially, S. aureus did not develop significant resistance to TPAMe-BODIPY even after 20 days of continuous exposure to sub-lethal concentrations.
Conclusions:
- TPAMe-BODIPY is a promising novel antibacterial agent effective against drug-resistant S. aureus and MRSA.
- The multi-targeted mechanism involving ROS generation likely prevents rapid resistance development.
- These findings offer new strategies for developing next-generation antibiotics to combat antimicrobial resistance.
More Related Videos
Related Concept Videos
01:18Surface Membrane Barriers
The outer layer of the skin, the epidermis, is a robust barrier comprising layers of closely packed keratinized cells. This dense arrangement prevents microbes from penetrating the body. The periodic shedding of epidermal cells...
01:28Antimicrobial Effectiveness